|
SAP30L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.756270E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.455440E-01 |
| Normal-vs-Stage2 |
8.961300E-03 |
| Normal-vs-Stage3 |
5.91810000005744E-07 |
| Normal-vs-Stage4 |
1.77260000011614E-07 |
| Stage1-vs-Stage2 |
6.724000E-02 |
| Stage1-vs-Stage3 |
4.22600000005158E-06 |
| Stage1-vs-Stage4 |
3.30380000002073E-06 |
| Stage2-vs-Stage3 |
2.252800E-01 |
| Stage2-vs-Stage4 |
1.734820E-01 |
| Stage3-vs-Stage4 |
7.223400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.350700E-04 |
| Normal-vs-AfricanAmerican |
1.683680E-03 |
| Normal-vs-Asian |
3.274200E-01 |
| Caucasian-vs-AfricanAmerican |
3.433400E-01 |
| Caucasian-vs-Asian |
7.972000E-01 |
| AfricanAmerican-vs-Asian |
5.507600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.237420E-04 |
| Normal-vs-Female |
4.123600E-03 |
| Male-vs-Female |
4.350000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.617870E-03 |
| Normal-vs-Age(41-60Yrs) |
5.915200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.035230E-04 |
| Normal-vs-Age(81-100Yrs) |
1.002440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.192200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.574400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.258000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.058000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.968200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.996800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.337000E-01 |
| Normal-vs-Grade 2 |
2.427200E-01 |
| Normal-vs-Grade 3 |
1.90129999999566E-05 |
| Normal-vs-Grade 4 |
2.78865819325347E-12 |
| Grade 1-vs-Grade 2 |
1.639810E-01 |
| Grade 1-vs-Grade 3 |
3.664200E-03 |
| Grade 1-vs-Grade 4 |
3.42320000012997E-07 |
| Grade 2-vs-Grade 3 |
2.793500E-04 |
| Grade 2-vs-Grade 4 |
5.49105205749356E-12 |
| Grade 3-vs-Grade 4 |
3.85620000000753E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.913600E-01 |
| Normal-vs-ccB subtype |
1.06120001674981E-09 |
| ccA subtype-vs-ccB subtype |
1.20015108961979E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.233700E-04 |
| Normal-vs-N1 |
1.88187999999867E-05 |
| N0-vs-N1 |
3.987500E-02 |
|
|
